Western pharmaceutical companies in China have been accepted capacity

Yesterday at the "new industries, large space, a total of development," high-level forum has always been low-key Haipu Rui Li Li, chairman of the biomedical industry trend was to judge. In this regard, Li Li said that this marks the Hai Purui product quality is accepted, Made in China

In yesterday's "new industries, the large space of the development of" high-level forum has always been low-key Haipu Rui Li Li, chairman of the biomedical industry trend was to judge. He believes that the era of globalization, only high-quality, high-end products have market, bio-pharmaceutical industry, the key is quality and stable production.

Li Li said: "If product quality and done well, they will never come to you, business development and even lose the chance of survival." From the biomedical industry, the first task is to process the guarantee, because the process directly related to to product quality. He said that Hai Purui factory in Shenzhen in 1998, just show the level of targeting with the U.S. close. But at the time the process is Haipu Rui innovation, the patent logic, not by the Western model, but open up a way to find new products. In his view, make the product structural integrity, the most important thing is to strictly control the entire production process, every process must withstand validation, good product quality is produced, not detected out.

Li Li emphasized that bio-pharmaceutical companies must have a good quality control system, the core of all behavior can be traced back, can be controlled. Now, Hai Purui be invited to participate in the U.S. pharmaceutical standards amendments. In this regard, Li Li said that this marks the Hai Purui product quality is accepted, the ability of pharmaceutical companies in China to be accepted.